Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  BMS-214662
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-6 of 6 for your search:
Start Over
BMS-214662 in Treating Patients With Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myeloid Leukemia
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 15 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02338, DM99-290, U01CA062461, CDR0000067887, MDA-DM-99290, NCI-450, 450, NCT00006213
BMS-214662 in Treating Patients With Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Not specified
Sponsor: NCI
Protocol IDs: NCI-2012-02343, ID99-304, U01CA062461, CDR0000067960, MDA-ID-99304, NCI-671, 671, NCT00005973
Paclitaxel and BMS-214662 in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CWRU4Y99, U01CA062502, P30CA043703, NCI-290, 290, NCT00006018
BMS-214662 in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00032, 00-003, U01CA062490, CDR0000068170, DFCI-00003, NCI-67, 67, NCT00006242
BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02396, FCCC-01013, CDR0000068828, NCI-139, 139, NCT00022529
Start Over